Antirheumatic Drug Treatment During Pregnancy and Lactation

References

• Anderson P. O. Drugs and breast feeding—a review. Drug Int Clin Pharm 1977; 11: 208
   Google Scholar
• Bischof P. Probleme der Rheumatherapie bei Schwangeren. Munch Med Wschr 1976; 118: 1323
   Google Scholar
• Blau S. P. Metabolism of gold during lactation. Arthr Rheum 1973; 16: 777
   PubMedGoogle Scholar
• Cecere F. A., Persellin R. H. The interaction of pregnancy and the rheumatic diseases. Clin Rheum Dis 1981; 7: 747
   Google Scholar
• Chaplin S., Sanders G. L., Smith J. M. Drug excretion in human breast milk. Adv Drug React Ac Pois Rev 1982; 1: 255
   Google Scholar
• Cohen D., Orzel J. Infants of mothers receiving gold therapy. Arthr Rheum 1981; 24: 104
   PubMedGoogle Scholar
• Committee on Drugs. The transfer of drugs and other chemicals into human breast milk. Pediatrics 1983; 72: 375
   PubMed Web of Science ®Google Scholar
• Crawhall J. C., Scowen E. F., Thompson C. J. Dissolution of cystine stones during d-penicillamine treatment of a pregnant patient with cystinuria. Brit Med J 1967; i: 216
   Google Scholar
• Collins E., Turner G. Maternal effects of regular salicylic ingestion in pregnancy. Lancet 1975; ii: 335
   Google Scholar
• Coté C. J., Meuwissen H. J., Pickering R. J. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974; 85: 324
   PubMed Web of Science ®Google Scholar
• Eeg-Olofssen O., Malmros I., Elwin C. E., Stéen B. Convulsions in a breastfed infant after maternal indometacin. Lancet 1978; ii: 215
   Google Scholar
• Synthetase inhibitors in obstetrics and after. Lancet 1980; ii: 591, Editorial
   Google Scholar
• Fine L. G. Systemic lupus erythematosus in pregnancy. Ann Int Med 1981; 94: 667
   PubMed Web of Science ®Google Scholar
• Fraga A., Mintz G., Orozco J., Orozco J. H. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1974; 1: 293
   Web of Science ®Google Scholar
• Gibbons R. B. Complications of chrysotherapy. Arch Int Med 1979; 139: 343
   PubMedGoogle Scholar
• Goudie B. M., Dossetor J. F. B. Effect on the fetus of indomethacin given to suppress labour. Lancet 1979; ii: 1187
   Google Scholar
• Gregory M. C., Mansell M. A. Pregnancy and cystinuria. Lancet 1983; ii: 1158
   Google Scholar
• Hart F. D. Medical disease in pregnancy. Proc R Soc Med 1959; 52: 769
   Google Scholar
• Hawkins D. F. Drug treatment of medical disorders in pregnancy. Drugs and Pregnancy, D. F. Hawkins. Churchill-Livingstone, Edinburgh, London, Melbourne 1983; 76
   Google Scholar
• Hayslett J. P., Lynn R. I. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980; 18: 207
   PubMed Web of Science ®Google Scholar
• Heinonen O. P., Slone D., Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton 1977; 286
   Google Scholar
• Houser M. T., Fish A. J., Tagatz G. E., Williams P. P., Michael A. T. Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 1980; 138: 409
   PubMed Web of Science ®Google Scholar
• Johns D. G., Rutherford L. D., Leighton P. C., Vogel C. L. Secretion of methotrexate into human milk. Am J Obstet Gynecol 1972; 112: 978
   PubMed Web of Science ®Google Scholar
• Maracek Z., Graf M. Pregnancy in penicillamine treated patients with Wilson's disease. N Engl J Med 1976; 295: 841
   Web of Science ®Google Scholar
• McKenzie Selley A.J., Agnew J. E. Secretion of prednisolone into breast milk. Arch Dis Child 1975; 50: 894
   PubMed Web of Science ®Google Scholar
• Linares A., Zarranz J. J., Rodriguez-Alarcon J., Diaz-Perez J. L. Reversible cutis laxa due to maternal D-penicillamine treatment. Lancet 1979; ii: 43
   Google Scholar
• Lyle W. H. Penicillamine in pregnancy. Lancet 1978; i: 606
   Google Scholar
• Matz G. J., Naunton R. F. Ototoxicity of chloroquine. Arch Oto Laryngol 1968; 88: 50
   Google Scholar
• Merland R., Cresté M. Study of the elimination and estimation of nivaquine in human milk. Med Trop 1951; 11: 793
   PubMedGoogle Scholar
• Mirkin B. L., Singh S. Placental transfer of pharmacologically active molecules. Perinatal Pharmacology and Therapeutics, B. L. Mirkin. Academic Press, New York 1976; 1–69
   Google Scholar
• Mjølnerud I. K., Rasmussen K., Dommerud S. A., Gjeruldsen S. T. Congenital connective tissue defect probably due to d-penicillamine treatment in pregnancy. Lancet 1971; i: 673
   Google Scholar
• Momma K., Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal antiinflammatory drugs. V International Conference on Prostaglandins. 1982, 253
   Google Scholar
• Nishimura H., Tanimura T. Clinical Aspects of the Teratogenicity of Drugs. Excerpta Medica, Elsevier Publ. Comp., New York 1976; 148
   Google Scholar
• Østensen M., Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthr Rheum 1983; 26: 1155
   PubMed Web of Science ®Google Scholar
• Østensen M. Piroxicam in human breast milk. Eur J Clin Pharm 1983; 25: 829
   PubMed Web of Science ®Google Scholar
• Perucca E., Crema A. Plasma protein binding of drugs in pregnancy. Clin Pharmacokin 1982; 7: 336
   PubMed Web of Science ®Google Scholar
• Read M. D. Prescribing for the breast feeding patient. The current position. Practitioner 1981; 22: 920
   Google Scholar
• Richards A. J. Transfer of gold from mother to fetus. Lancet 1977; i: 99
   Google Scholar
• Rocker J., Henderson M. Transfer of gold from mother to fetus. Lancet 1976; ii: 1246
   Google Scholar
• Ross J. B., Garatsos S. Absence of chloroquine-induced ototoxicity in a fetus. Arch Dermatol 1974; 109: 573
   PubMed Web of Science ®Google Scholar
• Scheinberg H., Sternlieb I. Pregnancy in penicillamine treated patients with Wilson's disease. N Engl J Med 1975; 293: 1300
   PubMed Web of Science ®Google Scholar
• Sidhu F. R. Corticosteroids in pregnancy. Drugs and Pregnancy, D. F. Hawkins. Churchill-Livingstone, Edinburgh, London, Melbourne 1983; 116
   Google Scholar
• Solomon L., Abrams G., Dinner M., Berman L. Neonatal abnormalities associated with d-penicillamine treatment during pregnancy. N Engl J Med 1977; 296: 55
   Web of Science ®Google Scholar
• Sørensen S. S. Farmakodynamiske undersøgelser på pasienter i behandling med guldpréparater. Nord Med 1970; 47: 1508
   Google Scholar
• Strobel Leuxner E. Über die Zulässigkeit der Verabreichung von Butazolidin bei Schwangeren und Wöchnerinnen. Med Klin 1957; 52: 1708
   PubMedGoogle Scholar
• Stuart M. J., Gross S. J., Eldrad H., Graeber J. E. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982; 307: 909
   PubMed Web of Science ®Google Scholar
• Symoens J., Veys E., Mielants M., Pinals R. Adverse reactions to levamisole. Cancer Treat Rep 1978; 62: 1721
   PubMedGoogle Scholar
• Szabo K. T., Guenriero J., Kang Y. J. The effect of gold-containing compounds on pregnant rats and their fetuses. Vet Path (Suppl. 5) 1978; 15: 89
   Google Scholar
• Szabo K. T., Di Febbo M. E., Phelan D. G. The effects of gold-containing compounds on pregnant rabbits and their fetuses. Vet Path (Suppl. 5) 1978; 15: 97
   Google Scholar
• Townsend R. J., Benedetti T., Erickson S., Gillespie W. R., Albert K. S. A study to evaluate the passage of ibuprofen into breast milk. Drug Intell Clin Pharm 1982; 16: 482
   Google Scholar
• Ullberg S., Lindquist N. G., Sjøestrand S. E. Accumulatin of chorioretinotoxic drugs in the foetal eye. Nature 1970; 227: 1257
   PubMed Web of Science ®Google Scholar
• Wiernik P. H., Duncan J. H. Cyclophosphamide in human milk. Lancet 1971; i: 912
   Google Scholar
• Wilkinson A. R., AynskyGreen A., Mitchell M. D. Persistent hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Child 1982; 54: 942
   Google Scholar